This contract involves the supply of radiopharmaceuticals and scintigraphy sets for the University Clinical Center (UCK). The specific types, estimated quantities, and requirements are detailed in Annex 3 of the procurement documents. All supplied items must meet the specifications outlined in Annex
Tender closed on 6 Nov 2025. Awaiting award.
This contract involves the supply of laboratory reagents and materials for IHC (Immunohistochemistry) and ISH (In Situ Hybridization) staining, along with the leasing of necessary equipment for the Clinical Pathology Department at the University Clinical Center. The required specifications, estimate
This procurement opportunity is part of the project aimed at enhancing the quality and accessibility of oncological diagnostics and treatment at the University Clinical Center (UCK). The project is funded under the National Recovery and Resilience Plan, specifically Component D, which focuses on imp
This contract involves the supply of lung perfusion products and buffered extracellular fluid for lung perfusion. Suppliers are required to provide the products as specified in Annex 3a and Annex 3b of the procurement documentation. The estimated quantities and specific requirements for these produc
This contract involves the delivery of pharmaceutical products as specified in the attached document (Annex 3 to the SWZ). The estimated quantity and specific requirements for the products are detailed in that annex. Suppliers are invited to provide these medical products to the University Clinical
Ireland is seeking a qualified occupational health services provider to deliver comprehensive workplace health assessments, medical surveillance, and occupational health advisory services.
NHSBT seeks suppliers of colour-coded EDTA sample tubes with bar-code labels to support testing of 1.5 million annual blood and tissue donations across two English facilities.
BHRUT seeks an outsourced dermatology service provider to treat 800 waiting list patients from November 2026 to March 2027 (£520,000 contract value).
A competitive NHS framework agreement enabling the supply of unlicensed imported medicines to healthcare organisations and eligible public bodies, subject to strict regulatory compliance and quality assurance standards.
